Anti-hypertensive Medication Use Among People with and Without Substance Use Disorders
Overview
Overview
Journal
J Gen Intern Med
Publisher
Springer
Specialty
General Medicine
Date
2023 Nov 27
PMID
38010465
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Varadarajan V, Ibe C, Young J
. Effect of substance use on premature mortality among severely hypertensive African Americans. J Clin Hypertens (Greenwich). 2022; 24(4):475-482.
PMC: 8989759.
DOI: 10.1111/jch.14420.
View
2.
Anderson K, Alexander G, Niles L, Scholle S, Saloner B, Dy S
. Quality of Preventive and Chronic Illness Care for Insured Adults With Opioid Use Disorder. JAMA Netw Open. 2021; 4(4):e214925.
PMC: 8033422.
DOI: 10.1001/jamanetworkopen.2021.4925.
View
3.
Wu L, Zhu H, Ghitza U
. Multicomorbidity of chronic diseases and substance use disorders and their association with hospitalization: Results from electronic health records data. Drug Alcohol Depend. 2018; 192:316-323.
PMC: 6358206.
DOI: 10.1016/j.drugalcdep.2018.08.013.
View
4.
Weber A, Miskle B, Lynch A, Arndt S, Acion L
. Services Available at United States Addiction Treatment Facilities That Offer Medications versus Behavioral Treatment Only: A Cross-Sectional, Observational Analysis. Subst Abuse Rehabil. 2022; 13:57-64.
PMC: 9464624.
DOI: 10.2147/SAR.S356131.
View
5.
Oliva E, Maisel N, Gordon A, Harris A
. Barriers to use of pharmacotherapy for addiction disorders and how to overcome them. Curr Psychiatry Rep. 2011; 13(5):374-81.
PMC: 4403628.
DOI: 10.1007/s11920-011-0222-2.
View